Clinical Trials Browser

INDUSTRY × lifileucel × Clear all

NCT07288203 2026-01-12

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Phase 2 Recruiting

Melanoma, Skin Neoplasms

NCT02360579 2025-12-09

LN-144

Phase 2 Completed

220 enrolled 15 charts 1 FDA

Melanoma

NCT06481592 2025-10-30

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Phase 2 Recruiting

Endometrial Neoplasms

NCT05727904 2025-07-08

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Phase 3 Recruiting

Melanoma, Skin Neoplasms

NCT03645928 2025-06-19

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Phase 2 Recruiting

DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma